课题基金 / 基金详情

项目摘要

项目成果

WANLI W SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肥胖是最常见的代谢疾病,是由于摄入的热量超过持续需求而引起的。肥胖患病率的增加导致肥胖相关疾病(例如 2 型糖尿病和心血管疾病)的发病率迅速加快。肥胖的发病机制仍不完全清楚。在当前的应用中,我们建议研究 synphilin-1 在食物摄入和体重控制中的新作用。 Synphilin-1 是一种细胞质蛋白,与 α-突触核蛋白和 Parkin 相互作用,对与蛋白质聚集相关的帕金森病发病机制有影响。通过检查 synphillin-1 转基因小鼠 (SP1) 的表型,我们有证据表明 synphilin-1 过度表达会显着增加体重,并且是通过增加食物摄入量来实现的。我们发现synphilin-1在参与能量平衡的下丘脑核神经元中高表达,表明synphilin-1可能通过调节下丘脑信号传导来影响能量平衡。我们的初步数据表明,synphilin-1 可能通过增加食欲基因(下丘脑神经元中的 NPY 和 AgRP 表达)来影响食物摄入和体重。最近的研究表明,AMP 激活激酶(AMPK)是一种中枢神经元能量传感器,在维持能量稳态中发挥着重要作用。我们的初步数据表明,人synphilin-1的表达增加了培养的N1E-115细胞和PVN位点的AMPK磷酸化,并进一步表明synphilin-1与AMPK相互作用,如免疫共沉淀所示。因此,在本提案中,我们将检验 synphilin-1 调节下丘脑进食相关基因表达和 AMPK 信号级联反应导致食欲过盛和肥胖的假设。在目标 1 中,我们将描述食物摄入量、体重和下丘脑基因表达模式对 synphilin-1 过度表达的反应的变化。我们将通过测试对中枢和外周肽给药的反应并表征它们的口味偏好,专门评估 SP1 小鼠进食过多特征的增加膳食量的基础。在目标 2 中,我们将研究内源性下丘脑 synphilin-1 在响应代谢状态变化中的作用。在目标 3 中,我们将在体外细胞培养系统中测试 synphilin-1 改变 AMPK 信号级联及其相关细胞能量事件的假设。在目标 4 中,我们将使用过度表达和 siRNA 敲低方法来测试 synphilin-1 激活下丘脑中的 AMPK 信号传导导致体内食欲亢进和肥胖的假设。这些研究将深入了解synphilin-1诱导的食欲亢进和肥胖的分子机制,扩大我们对synphilin-1生物学功能的了解,并可能为未来肥胖发病机制的研究提供独特的遗传性肥胖模型。
英文摘要
DESCRIPTION (provided by applicant): Obesity is the most common metabolic disease, resulting from the ingestion of calories in excess of ongoing requirements. Increased prevalence of obesity has resulted in rapidly accelerating rates of obesity related disorders such as type 2 diabetes and cardiovascular disease. The pathogenesis of obesity remains incompletely understood. In the current application, we propose to investigate a novel role for synphilin-1 in food intake and body weight control. Synphilin-1, a cytoplasmic protein, interacts with alpha-synuclein and parkin and has implications in Parkinson's disease pathogenesis related to protein aggregation. Through work examining the phenotype of a synphillin-1 transgenic mouse (SP1), we have evidence that synphilin-1 over- expression significantly increases body weight and does so through increasing food intake. We have found that synphilin-1 is highly expressed in neurons of hypothalamic nuclei involved in energy balance, suggesting that synphilin-1 may be affecting energy balance by modulating hypothalamic signaling. Our preliminary data suggest that synphilin-1 may affect food intake and body weight through increases in orexigenic genes: NPY and AgRP expression in hypothalamic neurons. Recently, studies have suggested that AMP-activated kinase (AMPK) is a central neuronal energy sensor that plays a major role in maintaining energy homeostasis. Our preliminary data showed that expression of human synphilin-1 increased AMPK phosphorylation in cultured N1E-115 cells and at the PVN site, and further showed that synphilin-1 interacted with AMPK as indicated by co-immunoprecipitation. Thus, in this proposal, we will test the hypothesis that synphilin-1 modulates hypothalamic feeding related gene expression and AMPK signaling cascades resulting in hyperphagia and obesity. In Aim 1, we will characterize changes in food intake, body weight and patterns of hypothalamic gene expression in responses to overexpression of synphilin-1. We will specifically assess the bases for the increased meal size that characterizes the hyperphagia in SP1 mice by testing responses to central and peripheral peptide administration and characterizing their taste preferences. In Aim 2, we will investigate the role of endogenous hypothalamic synphilin-1 in response to alterations in metabolic status. In Aim 3, we will test the hypothesis that synphilin-1 alters AMPK signaling cascades and its related cell energy events in an in vitro cell culture system. In Aim 4, we will test the hypothesis that synphilin-1 activates AMPK signaling in hypothalamus resulting in hyperphagia and obesity in vivo using overexpression and siRNA knockdown approaches. These studies will provide insight into the molecular mechanisms underlying synphilin-1-induced hyperphagia and obesity, will enlarge our knowledge of the biological functions of synphilin-1, and may provide a unique genetic obesity model for future studies of the pathogenesis of obesity.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0142314
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Smith WW, Smith M, Yang D, Choi PP, Moghadam A, Li T, Moran TH]
通讯作者: Moran TH
LRRK2, KIF5A and Parkinson disease
  • 批准号:
    9920786
  • 项目类别:
  • 资助金额:
    $41.63万
  • 财政年份:
    2016
  • 负责人:
    WANLI W SMITH
  • 依托单位:
LRRK2 dimerization and therapeutic evaluation
  • 批准号:
    9352885
  • 项目类别:
  • 资助金额:
    $24.02万
  • 财政年份:
    2016
  • 负责人:
    WANLI W SMITH
  • 依托单位:
LRRK2 dimerization and therapeutic evaluation
  • 批准号:
    9243623
  • 项目类别:
  • 资助金额:
    $21.45万
  • 财政年份:
    2016
  • 负责人:
    WANLI W SMITH
  • 依托单位:
Synphilin-1 and obesity
  • 批准号:
    7992235
  • 项目类别:
  • 资助金额:
    $40.15万
  • 财政年份:
    2010
  • 负责人:
    WANLI W SMITH
  • 依托单位:
海外基金